comparemela.com

Latest Breaking News On - Medical education programs - Page 3 : comparemela.com

EQS-Adhoc: Medacta Group SA reports 35 4% growth at constant currency of half-year revenue and revises upward the revenue target for 2021

(2) EQS Group-Ad-hoc: Medacta Group SA / Key word(s): Sales Result Medacta Group SA reports 35.4% growth at constant currency of half-year revenue and revises upward the revenue target for 2021 20-Jul-2021 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Press Release - Ad-hoc announcement pursuant to Art. 53 LR Medacta Group SA reports 35.4% growth at constant currency of half-year revenue and revises upward the revenue target for 2021 - 1H 2021 revenue increased to Euro 177.5 million, or 35.4% at constant currency (31.7% reported) vs 1H 2020. - The growth was driven by significant carry-over and customer acquisition, in addition to faster-than-expected normalization of surgery activities, with positive contributions from all business lines and geographies.

EQS-Adhoc: Medacta Group SA: Medacta Group reports 35 4% growth at constant currency of half-year revenue and revises upward the revenue target for 2021

EQS-Adhoc: Medacta Group SA: Medacta Group reports 35 4% growth at constant currency of half-year revenue and revises upward the revenue target for 2021
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

EQS-Adhoc: Medacta Group SA: 2020 Preliminary unaudited top-line figures

EQS-Adhoc: Medacta Group SA: 2020 Preliminary unaudited top-line figures 2020 Preliminary unaudited top-line figures 21-Jan-2021 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR The issuer is solely responsible for the content of this announcement. Press Release - 2020 Preliminary unaudited top-line figures Medacta Group SA continues to outperform the market [1] with a strong revenue acceleration in the second semester 2020 - FY 2020 revenues were €302.5 million, only -2.1% on a constant currency basis, -2.6% reported vs 2019 - 2H revenues to €167.7 million, +7.6% on a constant currency basis, largely compensating 1H results - 2H acceleration sustained by both pent-up demand and new customers acquired

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.